These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19397462)

  • 1. Management of peripheral arterial disease in primary care.
    Burns P; Gough S; Bradbury AW
    BMJ; 2003 Mar; 326(7389):584-8. PubMed ID: 12637405
    [No Abstract]   [Full Text] [Related]  

  • 2. Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities.
    de Havenon A; Sheth KN; Madsen TE; Johnston KC; Turan TN; Toyoda K; Elm JJ; Wardlaw JM; Johnston SC; Williams OA; Shoamanesh A; Lansberg MG
    Stroke; 2021 Oct; 52(10):e635-e645. PubMed ID: 34517768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis.
    Enns JE; Yeganeh A; Zarychanski R; Abou-Setta AM; Friesen C; Zahradka P; Taylor CG
    BMC Cardiovasc Disord; 2014 May; 14():70. PubMed ID: 24885361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting phosphodiesterases in anti-platelet therapy.
    Rondina MT; Weyrich AS
    Handb Exp Pharmacol; 2012; (210):225-38. PubMed ID: 22918733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inorganic nitrite and chronic tissue ischaemia: a novel therapeutic modality for peripheral vascular diseases.
    Pattillo CB; Bir S; Rajaram V; Kevil CG
    Cardiovasc Res; 2011 Feb; 89(3):533-41. PubMed ID: 20851809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral artery disease: current insight into the disease and its diagnosis and management.
    Olin JW; Sealove BA
    Mayo Clin Proc; 2010 Jul; 85(7):678-92. PubMed ID: 20592174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatment options in intermittent claudication: the US experience.
    Hiatt WR
    Int J Clin Pract Suppl; 2001 Apr; (119):20-7. PubMed ID: 11355276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of peripheral arterial disease and intermittent claudication.
    Schainfeld RM
    J Am Board Fam Pract; 2001; 14(6):443-50. PubMed ID: 11757887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The US experience with cilostazol in treating intermittent claudication.
    Hiatt WR
    Atheroscler Suppl; 2005 Dec; 6(4):21-31. PubMed ID: 16275166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
    Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME
    Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with intermittent claudication.
    Olin JW
    Int J Clin Pract; 2002 Nov; 56(9):687-93. PubMed ID: 12469984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic therapy for intermittent claudication.
    Dobesh PP; Stacy ZA; Persson EL
    Pharmacotherapy; 2009 May; 29(5):526-53. PubMed ID: 19397462
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.